Plain-English translation of NCT07564414 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This clinical trial is testing a new medication called to see if it helps people with obesity lose weight. The study will compare at two different dose levels against , a medication doctors already prescribe for weight loss. Researchers want to find out which treatment works best and is safest for people living with obesity, whether or not they also have type 2 diabetes.
Current weight loss treatments don't work well enough for everyone, and doctors need more options to help people with obesity manage their weight and health. This medication is being tested to see if it could be a more effective choice for patients who struggle with weight loss.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to receive one of three treatments: at a lower dose, at a higher dose, or . You'll give yourself an injection under the skin once a week for about 72 weeks (roughly 18 months). The entire study will last about 83 weeks, during which you'll have regular visits to check your weight, health, and how well the medication is working.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States